US Broker Ratings

DaVita Inc. (DVA) Investor Outlook: Uncovering an 18.53% Upside in the Healthcare Sector

DaVita Inc. (DVA), a prominent player in the healthcare sector, particularly in the realm of medical care facilities, has caught the attention of investors with its..

Charles River Laboratories (CRL) Stock Analysis: Navigating a 13.45% Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, particularly within the diagnostics and research industry. With a market..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovation with a 12% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $10.54 billion,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 69% Upside Potential Beckons Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a renowned name in the biotechnology sector, focusing on the development and commercialization of therapies for rare and life-threatening diseases...

Solventum Corporation (SOLV) Stock Analysis: Evaluating an 18% Potential Upside in Healthcare Innovation

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is generating buzz with its unique blend of medical solutions and promising financial metrics. Based..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Powerhouse with 6.66% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) has positioned itself as a leading player in the healthcare sector, particularly within the medical care facilities industry. With a..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Navigating a Potential 20.76% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its cutting-edge approach to medicinal therapies. Founded in 2003..

Genmab A/S (GMAB) Stock Analysis: Exploring a 42% Potential Upside for Investors

For investors with a keen eye on the biotechnology sector, Genmab A/S (GMAB) represents a compelling opportunity. This Danish company, with a market capitalization of $13.9..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Gem with 86% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a key player in the biotechnology sector, is making waves with its promising portfolio of treatments tackling severe endocrinologic, oncologic, metabolic,..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Upside Potential of 19.58%

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology industry with its notable presence in the oncology sector, focusing on the development and commercialization of innovative..

Moderna, Inc. (MRNA) Investor Outlook: Analyzing the 71.73% Potential Upside Amidst Challenges

Moderna, Inc. (NASDAQ: MRNA), a pioneering biotechnology company, has been a subject of intense investor scrutiny as it navigates the complexities of the post-pandemic landscape. Known..

Tenet Healthcare Corporation (THC) Stock Analysis: Unpacking a 19% Potential Upside with Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC), a leading entity in the healthcare sector, is capturing investor attention with its robust market position and promising growth potential. With..

Walgreens Boots Alliance (WBA) Stock Analysis: Navigating Challenges with an 8.38% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, has been a focal point for investors seeking stability and dividends..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring the 26.65% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, stands as a formidable player in the U.S. healthcare sector. With a robust market..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and 14% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands as a prominent player in the healthcare sector, particularly within the medical distribution industry. With a substantial market capitalization of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Buy Ratings and 18.45% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare sector as a formidable player in the Diagnostics & Research industry. With a significant market capitalization..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Look at Growth and Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the healthcare sector, continues to capture the attention of investors with its innovative medical devices designed for..

Mettler-Toledo International, Inc. (MTD): Investor Outlook and Valuation Insights Amidst Modest Growth

Mettler-Toledo International, Inc. (MTD), a prominent player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its robust market..

Humana Inc. (HUM) Stock Analysis: Evaluating a 9.12% Potential Upside Amidst Healthcare Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, has captured the attention of investors with its robust market position and promising growth prospects...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Key Insights into the 33% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology industry, commands significant attention with its robust portfolio of therapies targeting cystic fibrosis (CF) and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds